Physician profile
Shashank Agarwal
NPI 1255885554
$561.94
in general payments reported to CMS, 2019-2025
8 companies · $401 in 2025
The $401 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $44.40 · 2024: $117 · 2025: $401.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $562.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $561.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rapid Medical LTD | $142.11 | 2025 | Tigertriever 17 Revascularization Device, Comaneci 17 |
| Imperative Care, INC | $134.29 | 2025 | Zoom 88-T Large Distal Platform |
| Asahi Intecc USA, INC. | $124.32 | 2025 | Asahi Neurology Wires |
| Penumbra, INC. | $61.80 | 2024 | Benchmark |
| Silk Road Medical, INC. | $30.16 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| W. L. Gore & Associates, INC. | $27.79 | 2023 | Gore Excluder Aaa Endoprosthesis |
| Alnylam Pharmaceuticals INC. | $24.86 | 2024 | Onpattro |
| E.R. Squibb & Sons, L.L.C. | $16.61 | 2023 | Eliquis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shashank Agarwal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.